只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 5 | US$711.49 | US$3,557.45 | 17,506 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 1 | US$712.09 | US$712.09 | 17,505 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 2 | US$714.13 | US$1,428.26 | 17,503 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 4 | US$707.40 | US$2,829.60 | 17,519 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 6 | US$709.45 | US$4,256.70 | 17,513 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 7 | US$706.74 | US$4,947.18 | 17,523 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 14 | US$705.56 | US$9,877.84 | 17,530 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 15 | US$704.28 | US$10,564.20 | 17,544 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 24 | US$703.46 | US$16,883.04 | 17,559 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 5 | US$701.76 | US$3,508.80 | 17,598 | SEC |
| 2026-05-01 2026-05-04 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 15 | US$702.46 | US$10,536.90 | 17,583 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 13 | US$776.62 | US$10,096.06 | 17,656 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 9 | US$777.42 | US$6,996.78 | 17,647 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 4 | US$778.24 | US$3,112.96 | 17,643 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 40 | US$779.71 | US$31,188.40 | 17,603 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 14 | US$775.58 | US$10,858.12 | 17,669 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 8 | US$773.59 | US$6,188.72 | 17,691 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 3 | US$772.76 | US$2,318.28 | 17,699 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 1 | US$771.32 | US$771.32 | 17,702 | SEC |
| 2026-04-01 2026-04-03 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 8 | US$774.58 | US$6,196.64 | 17,683 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| REGN | 286,868.8709 | 28,372 | 439,202.6548 | 65.32% | B, Q, N |